Pharmaceuticals - New York, New York, United States
Corvidane is developing Corvida™ to treat TWO formidable diseases.Corvidane uses a novel approach to treat metabolic and inflammatory diseases.Corvida(TM) for Atherosclerosis - In development to be a Best-in-Class, orally administered adjunct to lipid regulating therapies (Statins/PCSK9) that targets atherosclerotic plaques, the major factor in Heart Attacks and Stroke.Corvida(TM) for NASH - In development to be a Best-in-Class, orally administered drug to treat NASH, which is the leading cause of liver transplants in the United States.
Outlook
Varnish
Wix
Google Cloud Hosting
Mobile Friendly